期刊论文详细信息
BMC Psychiatry
Risk and protective factors for relapse among Individuals with Schizophrenia: A Qualitative Study in Dar es Salaam, Tanzania
Khadija IY Malima2  Anne H Outwater3  Adellah E Sariah1 
[1]Hubert Kairuki Memorial University (HKMU), Faculty of Nursing, 322 Regent Estate, Dar es Salaam, Tanzania
[2]Tanzania Commission for Science and Technology (COSTECH), Dar es Salaam, Tanzania
[3]School of Nursing, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania
关键词: Africa;    Tanzania;    Protective factors;    Risk factors;    Caregivers;    Schizophrenia;    Relapse;   
Others  :  1123370
DOI  :  10.1186/s12888-014-0240-9
 received in 2013-12-30, accepted in 2014-08-15,  发布年份 2014
PDF
【 摘 要 】

Background

Relapse in people with schizophrenia is a major challenge for mental health service providers in Tanzania and other countries. Approximately 10% of people with schizophrenia are re-admitted due to relapse at Muhimbili National Hospital (MNH) Psychiatric Unit each month. Relapse brings about negative effects and it results in a huge burden to patients, their families, the mental health sector and the country’s economy. So far no study has been done to address relapse in Tanzania. The purpose of the study was to explore perspectives on risk and protective factors influencing relapse of people with schizophrenia and their caregivers attending Muhimbili National Hospital Psychiatric Out-patient Department, Dar es Salaam, Tanzania.

Methods

A qualitative study was conducted, involving in-depth interviews of seven people with schizophrenia who are out-patients and their seven family caregivers at MNH. Purposive sampling procedure was used to select participants for the study. Audio recorded in-depth interviews in Swahili language were conducted with all study participants. The recorded information was transcribed and analyzed using NVivo 9 computer assisted qualitative data analysis software.

Results

Personal risk and protective factors for relapse, environmental risk and protective factors for relapse and suggestions to reduce relapse were the main themes that emerged from this study. People with schizophrenia and their caregivers (all of whom were relatives) perceived non adherence to antipsychotic medication as a leading risk factor of relapse; other risks included poor family support, stressful life events and substance use. Family support, adherence to antipsychotic medication, employment and religion were viewed as protective factors. Participants suggested strengthening mental health psycho-education sessions and community home visits conducted by mental health nurses to help reduce relapse. Other suggestions included strengthening the nurse-patient therapeutic relationship in provision of mental health care.

Conclusions

This study calls for improvement in mental health care service delivery to individuals with schizophrenia. Establishing a curricular in mental health nursing that aims to produce competent mental health nurse force would improve nursing practice in mental health care service delivery.

【 授权许可】

   
2014 Sariah et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150216031638133.pdf 450KB PDF download
Figure 1. 61KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]McGrath Saha J, Welham SJ, El Saadi O, MacCauley C, Chant D: A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. Biomed Central, Psychiatry; 2004.
  • [2]Gelder MG, Lopez-Ibor JJ, Andreasen NC: New Oxford Textbook of Psychiatry. Oxford University Press, Oxford; 2000.
  • [3]Schennach R, Obermeier M, Meyer S, Jäger M, Schmauss M, Laux G: Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv 2012, 63:87-90.
  • [4]The great push: Investing in mental health. WHO, Geneva; 2001.
  • [5]Piggot TA, Carson WH, Saha AR, Torbeyns AF, Ingenito GG: Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry 2003, 64:1048-1056.
  • [6]Kazadi NJB, Moosa MYH, Jeenah FY: Factors associated with relapse in schizophrenia. South Afr J Psychiatr 2008, 14:52-62.
  • [7]Tanzania Demographic and Health Survey. National Bureau of Statistics, Dar es Salaam; 2010.
  • [8]Dar es Salaam Regional Commissioner’s Office: Strategic plan for 2010/11-2012/13. president's office, Dar es Salaam; 2010.
  • [9]Polit DE, Beck CT: Essentials of Nursing Research: Methods, Appraisal, and Utilization. Lippincott Williams and Wilkins, Philadelphia; 2006.
  • [10]Graneheim UH, Lundman B: Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurses Educ Today 2004, 24:105-112.
  • [11]Polit DF, Hungler BP: Nursing Research: Principles and Methods. J.B. Lippincott Company, Philadelphia; 1995.
  • [12]Liu-Seifert H, Osuntokun OO, Godfrey JL, Feldman PD: Patient perspectives on antipsychotic treatments and their association with clinical outcomes. Patient Preference Adherence 2010, 4:369-377.
  • [13]Suttajit S, Pilakanta S: Impact of depression and social support on non adherence to antipsychotic drugs in persons with schizophrenia in Thailand. Patient Preference Adherence 2010, 4:363-368.
  • [14]DiBonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E: A patient perspective of the impact of medication side effects on adherence: results of a cross sectional nationwide survey of patients with schizophrenia. BMC Psychiatr 2012, 12:20. BioMed Central Full Text
  • [15]Tandon R, Henry A, Nasrallah HA, Keshavan MS: Schizophrenia, just the facts for Clinical features and conceptualization. Schizophr Res 2009, 110:1-23.
  • [16]Sharif SA, Ogunbanjo GA: Reasons for non compliance to treatment among patients with psychiatric illness: A qualitative study. South Afr Fam Pract 2003, 45:10-13.
  • [17]Thara R, Padmavati R, Aynkran JR, John S: Community mental health in India: A rethink. Int J Ment Heal Syst 2008, 2:11. BioMed Central Full Text
  • [18]Mansouri N, Chimeh N, Dehghani M, Malakouti SK, Taherkhani H, Abarashi Z: Risk factors associated with psychiatric hospitalization among Iranian schizophrenic patients. Iran J Psychiatr Behavior Sci 2013, 7:16-23.
  • [19]Egbe OC, Brooke-Sumner C, Kathree T, Selohilwe O, Thornicrof G, Petersen I: Psychiatric stigma and discrimination in South Africa: Perspectives from key stakeholders. BMC Psychiatr 2014, 14:191. BioMed Central Full Text
  • [20]Reddy SK, Thirthali J, Channaveerachari NK, Reddy KN, Ramareddy RN, Rawat VS, Narayana M, Ramkrishna J, Gangadhar BN: Factors influencing access to psychiatric treatment in persons with schizophrenia: A qualitative study in a rural community. Indian J Psychiatry 2014, 56:54-60.
  • [21]Marom S, Munitz H, Jones PB, Weizman A, Hermesh A: Familial Expressed Emotion: Outcome and Course of Israeli Patients with Schizophrenia. Schizophr Bull 2002, 28:731-743.
  • [22]Betensky JD, Robinson DG, Gunduz-Bruce H, Sevy S, Lencz T, Kane JM, Malhotra AK, Miller R, McCormack J, Bilder RM, Szesko PR: Patterns of stress in schizophrenia. Psychiatry Res 2008, 160:38-46.
  • [23]Hambrecht M, Häfner H: Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust N Z J Psychiatry 2000, 34:468-475.
  • [24]Volcow ND: Substance use disorders in schizophrenia, clinical implications of comorbidity. Schizophr Bull 2009, 35:469-472.
  • [25]Hall W, Degenhardt L: Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry 2000, 34:26-34.
  • [26]Gregg L, Barrowclough C, Haddock G: Reasons for increased substance use in psychosis. Clin Psychol Rev 2007, 27:494-510.
  • [27]Avasthi A: Preserve and strengthen family to promote mental health. Indian J Psychiatry 2010, 52:113-126.
  • [28]Hamada Y, Octa Y, Nakane Y: Factors affecting the family support system of patients with schizophrenia: a survey in the remote island of Tsushima. Psychiatry Clin Neurosci 2003, 57:161-168.
  • [29]Chieng WT, Chan SWC, Morrissey J: The perceived burden among Chinese family caregivers of people with schizophrenia. J Clin Nurs 2005, 16:1151-1161.
  • [30]Pernice-Duca F: Family network support and mental health recovery. J Marital Fam Ther 2010, 36:13-27.
  • [31]Sawant NS, Jethwani KS: Understanding family functioning and social support in unremitting schizophrenia: A study in India. Indian J Psychiatry 2010, 52:145-149.
  • [32]Wagner LC, King M: Existential needs of people with psychotic disorders in Pôrto Alegre, Brazil. Br J Psychiatry 2005, 186:141-145.
  • [33]Moran GS, Nemec PB: Walking on the sunny side: What positive psychology can contribute to psychiatric rehabilitation concepts and practice. Psychiatr Rehabil J 2013, 36:202-208.
  • [34]Fallot RD: Spirituality and religion in recovery: Some current issues. Psychiatr Rehabil J 2007, 30:261-270.
  • [35]Borras L, Mohr S, Brandt YP, Gillie´Ron C, Eytan A, Huguelet P: Religious Beliefs in Schizophrenia: Their Relevance for Adherence to Treatment. Schizophr Bull 2007, 33:1238-1246.
  • [36]Gunnmo P, Bergman HF: What do individuals with schizophrenia need to increase their well-being.Int J Qual Studies Health Well-being 2011, 6.
  • [37]Dunn EC, Wewiorski NJ, Rogers ES: The meaning and importance of employment to people in recovery from serious mental illness: results of a qualitative study. Psychiatr Rehabil J 2008, 32:59-62.
  • [38]Scanlon A: Psychiatric nurses perceptions of the constituents of the therapeutic relationship: a grounded theory study. J Psychiatr Ment Health Nurs 2006, 13:319-329.
  • [39]Gilburt H, Rose D, Slade M: The importance of relationships in mental health care: A qualitative study of the service users’ experiences of psychiatric hospital admission in the UK. BMC Health Serv Res 2008, 8:92. BioMed Central Full Text
  • [40]Cheng JF, Huang XY, Hsu YS, Su CH: Influencing factors of community mental health nurses caring for people with schizophrenia in Taiwan. J Psychiatr Mental Health Nursing 2012, 19:319-326.
  • [41]McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rossler W: The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia.PLoS One 2012, 7.
  • [42]Moran GS, Zisman-Ilani Y, Epstein G, Roe D: Adaptation and psychometric assessment of the Hebrew version of the recovery promotion relationships scale (RPRS). Psychiatr Rehabil J 2014, 37:31-36.
  • [43]Huang XY, Ma WF, Shih HH, Li HF: Roles and functions of community mental health nursing. J Clin Nurs 2008, 17:3030-3040.
  • [44]Xia J, Merinder LB, Belgamwar MR: Psychoeducation for Schizophrenia. Schizophr Bull 2011, 37:21-22.
  • [45]Nose MC, Barbui C, Tansella M: How often do patients with psychosis fail to adhere to treatment programmes: A systematic review. Psychol Med 2003, 33:1149-1160.
  • [46]Cassidy E, Hill S, O’Callaghan E: Efficacy of a psychoeducational intervention in improving relatives’ knowledge about schizophrenia and reducing rehospitalization. Eur Psychiatry 2001, 16:446-450.
  文献评价指标  
  下载次数:37次 浏览次数:32次